跳至主要内容
临床试验/IRCT20191105045340N3
IRCT20191105045340N3尚未招募3 期

The effect of nanocurcumin and omega-3 supplementation on quality of life in patients with asthma

Iran University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 60 years(—)
性别
All

入选标准

  • Patients with asthma diagnosed by a doctor
  • Asthma patients with an age range of 15 to 60 years

排除标准

  • Users of systemic drugs, NSAIDs, immunosuppressive drugs
  • NSAID users
  • Users of immunosuppressive drugs
  • People with COPD
  • Cardiovascular patients
  • Kidney patients
  • Liver patients
  • Gastrointestinal patients
  • Autoimmune patients
  • suffering from reflexes
  • Lactating lady
  • pregnant lady
  • People addicted to tobacco
  • Allergy and intolerance to curcumin
  • Allergy and intolerance to fish oil
  • Consumption of food supplements and antioxidants from 2 months before and during the study

研究者

相似试验